Can a smart sensor keep heart failure patients out of the hospital?
NCT ID NCT07045298
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using a real-time continuous glucose monitor (CGM) can improve blood sugar control and reduce hospital readmissions in people with type 2 diabetes and acute heart failure. Researchers will follow 140 adults during their hospital stay and for three months after discharge, comparing CGM to standard finger-stick testing. The goal is to see if better glucose monitoring can prevent dangerous blood sugar swings and lower the risk of returning to the hospital.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
FreeStyle Libre 2 continuous glucose monitor (CGM)
What this could lead to
If successful, this could show that real-time CGM helps people with type 2 diabetes and heart failure avoid dangerous blood sugar swings and reduce repeat hospital visits.
What could go wrong
This is a small, early-stage study (140 participants) that has not yet started. It focuses on monitoring, not a new drug, so the impact on hospital readmissions may be modest or unclear.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Grady Health System
Atlanta, Georgia, 30303, United States